MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 99 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,013 | +29.6% | 221,946 | +6.1% | 0.01% | +42.9% |
Q2 2023 | $5,413 | +1760.1% | 209,252 | +1629.6% | 0.01% | – |
Q1 2023 | $291 | +33.5% | 12,098 | +8.4% | 0.00% | – |
Q4 2022 | $218 | -99.9% | 11,165 | -0.1% | 0.00% | – |
Q3 2022 | $235,000 | +9.3% | 11,173 | +1.2% | 0.00% | – |
Q2 2022 | $215,000 | +571.9% | 11,042 | +661.5% | 0.00% | – |
Q1 2022 | $32,000 | -63.2% | 1,450 | -73.4% | 0.00% | – |
Q4 2021 | $87,000 | -20.2% | 5,450 | 0.0% | 0.00% | – |
Q3 2021 | $109,000 | +16.0% | 5,450 | -0.2% | 0.00% | – |
Q2 2021 | $94,000 | -12.1% | 5,462 | +0.9% | 0.00% | – |
Q1 2021 | $107,000 | +13.8% | 5,412 | 0.0% | 0.00% | – |
Q4 2020 | $94,000 | -9.6% | 5,412 | 0.0% | 0.00% | – |
Q3 2020 | $104,000 | +70.5% | 5,412 | +73.9% | 0.00% | – |
Q2 2020 | $61,000 | +165.2% | 3,112 | +93.1% | 0.00% | – |
Q1 2020 | $23,000 | -42.5% | 1,612 | 0.0% | 0.00% | – |
Q4 2019 | $40,000 | -32.2% | 1,612 | -72.7% | 0.00% | – |
Q3 2019 | $59,000 | – | 5,912 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RiverVest Venture Management LLC | 1,921,118 | $38,269,000 | 6.42% |
FRAZIER MANAGEMENT LLC | 3,566,912 | $71,053,000 | 5.68% |
Novo Holdings A/S | 2,445,147 | $48,707,000 | 2.52% |
Sio Capital Management, LLC | 248,978 | $4,960,000 | 1.58% |
Mesirow Financial Investment Management, Inc. | 25,795 | $514,000 | 1.51% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,282,912 | $65,396,000 | 1.28% |
NEA Management Company, LLC | 4,187,801 | $83,421,000 | 0.99% |
MPM BioImpact LLC | 308,532 | $6,146,000 | 0.95% |
Rock Springs Capital Management LP | 1,525,623 | $30,390,000 | 0.64% |
BVF INC/IL | 435,936 | $8,684,000 | 0.34% |